//Forge Therapeutics Participating in Upcoming San Diego Events

Forge Therapeutics Participating in Upcoming San Diego Events

San Diego, Calif., June 1, 2016 – Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting metalloproteins, announced today its participation at the following upcoming events:

 

Cool Company: San Diego Venture Group has selected Forge Therapeutics a ‘2016 Cool Company’ and only 20 start-up companies across all technology areas will be in attendance.

When: Tuesday June 7 from 4:00 pm – 6:30 pm

Where: 10996 Torreyana Road, San Diego, CA 92121

Website: http://www.sdvg.org/meetthecool/

 

San Diego Start-up Week: Zachary A. Zimmerman, Ph.D., CEO of Forge, will participate on two panel discussions entitled “Starting a Biotech Company – JUST DO IT!” and “Licensing IP from UCSD and other Research Institutions”.

When: Monday June 13 at 10:45 am & 12:15 pm

Where: 2880 Torrey Pines Scenic Drive, La Jolla, CA 92037

Website: http://sandiegostartupweek.com/

 

BIOCOM: Zachary A. Zimmerman will participate on a panel entitled “Capital Markets Update” discussing pros & cons of equity financing and non-dilutive options.

When: Wednesday June 15 from 8:00 am – 10:00 am

Where: 10996 Torreyana Road, San Diego, CA 92121

Website: https://www.biocom.org/s/EventDetail?event=capital_markets_2016

 

CONNECT: Forge Therapeutics has been selected a ‘Showcase Company’ at Connect with CONNECT.

When: Tuesday, June 21 from 5:00 pm – 7:00 pm

Where: 3210 Merryfield Row, San Diego, CA 92121

Website: http://www.connect.org/events/connect-connect;

 

About Forge Therapeutics, Inc.

Forge Therapeutics, Inc. (“Forge”) is a biotechnology start-up that leverages its novel chemistry platform to develop small molecule inhibitors to target metalloproteins. Metalloproteins are proteins that require metal ions for their biological function and make up over 1/3 of the proteins in the human body. Forge uses a proprietary approach comprised of molecular modeling for rational drug design along with fundamental knowledge and expertise in bioinorganic chemistry to target metalloproteins.  The name Forge Therapeutics comes from two definitions for forge: to manipulate (inhibit) a metal object (metalloprotein) and to move forward steadily with a purpose (the Forge team). Forge Therapeutics, Inc., maintains its headquarters in San Diego, California. To learn more please visit www.ForgeTherapeutics.com.

 

Contact:

Info@ForgeTherapeutics.com

2017-10-10T16:13:15+00:00May 31st, 2016|

Leave A Comment